Literature DB >> 22431528

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Debbie Saslow1, Diane Solomon, Herschel W Lawson, Maureen Killackey, Shalini L Kulasingam, Joanna Cain, Francisco A R Garcia, Ann T Moriarty, Alan G Waxman, David C Wilbur, Nicolas Wentzensen, Levi S Downs, Mark Spitzer, Anna-Barbara Moscicki, Eduardo L Franco, Mark H Stoler, Mark Schiffman, Philip E Castle, Evan R Myers.   

Abstract

An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical precancerous lesions and cancer is presented. The guidelines are based on a systematic evidence review, contributions from 6 working groups, and a recent symposium cosponsored by the ACS, the American Society for Colposcopy and Cervical Pathology, and the American Society for Clinical Pathology, which was attended by 25 organizations. The new screening recommendations address age-appropriate screening strategies, including the use of cytology and high-risk human papillomavirus (HPV) testing, follow-up (eg, the management of screen positives and screening intervals for screen negatives) of women after screening, the age at which to exit screening, future considerations regarding HPV testing alone as a primary screening approach, and screening strategies for women vaccinated against HPV16 and HPV18 infections.

Entities:  

Mesh:

Year:  2012        PMID: 22431528     DOI: 10.1309/AJCPTGD94EVRSJCG

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  209 in total

1.  Point-Counterpoint: The FDA Has a Role in Regulation of Laboratory-Developed Tests.

Authors:  Angela M Caliendo; Kimberly E Hanson
Journal:  J Clin Microbiol       Date:  2016-01-20       Impact factor: 5.948

2.  Excess Cost of Cervical Cancer Screening Beyond Recommended Screening Ages or After Hysterectomy in a Single Institution.

Authors:  Deanna Teoh; Gretchen Hultman; McKenzie DeKam; Rachel Isaksson Vogel; Levi S Downs; Melissa A Geller; Chap Le; Genevieve Melton; Shalini Kulasingam
Journal:  J Low Genit Tract Dis       Date:  2018-07       Impact factor: 1.925

3.  HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections.

Authors:  Anna Manawapat-Klopfer; Lisa Wang; Juliane Haedicke-Jarboui; Frank Stubenrauch; Christian Munk; Louise T Thomsen; Peter Martus; Susanne K Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

Review 4.  Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.

Authors:  Megan A Clarke; Nicolas Wentzensen; Lisa Mirabello; Arpita Ghosh; Sholom Wacholder; Ariana Harari; Attila Lorincz; Mark Schiffman; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

5.  Calcium-activated potassium channels as potential early markers of human cervical cancer.

Authors:  Ana Ramírez; Eunice Vera; Armando Gamboa-Domínguez; Paul Lambert; Patricio Gariglio; Javier Camacho
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

6.  Single human papillomavirus 16 or 52 infection and later cytological findings in Japanese women with NILM or ASC-US.

Authors:  Shuhei Abe; Kiyonori Miura; Akira Kinoshita; Hiroyuki Mishima; Shoko Miura; Kentaro Yamasaki; Yuri Hasegawa; Ai Higashijima; Ozora Jo; Atsushi Yoshida; Masanori Kaneuchi; Koh-Ichiro Yoshiura; Hideaki Masuzaki
Journal:  J Hum Genet       Date:  2014-02-13       Impact factor: 3.172

7.  Cervical carcinoma rates among young females in the United States.

Authors:  Vicki B Benard; Meg Watson; Philip E Castle; Mona Saraiya
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

8.  Testing and genotyping of high-risk human papillomavirus by the cobas HPV Test and the Hybrid Capture 2 high-risk HPV DNA test using cervical and vaginal samples.

Authors:  Michael T Pyne; Christian Law; David R Hillyard; Robert Schlaberg
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

9.  A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States.

Authors:  Patti E Gravitt; Anne F Rositch; Michelle I Silver; Morgan A Marks; Kathryn Chang; Anne E Burke; Raphael P Viscidi
Journal:  J Infect Dis       Date:  2012-12-12       Impact factor: 5.226

10.  Implementation of the National Breast and Cervical Cancer Early Detection Program: the beginning.

Authors:  Nancy C Lee; Faye L Wong; Patricia M Jamison; Sandra F Jones; Louise Galaska; Kevin T Brady; Barbara Wethers; George-Ann Stokes-Townsend
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.